Jeffrey Graham

1.3k total citations
56 papers, 591 citations indexed

About

Jeffrey Graham is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Jeffrey Graham has authored 56 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 26 papers in Cancer Research and 24 papers in Molecular Biology. Recurrent topics in Jeffrey Graham's work include Renal cell carcinoma treatment (43 papers), Cancer Genomics and Diagnostics (25 papers) and Renal and related cancers (23 papers). Jeffrey Graham is often cited by papers focused on Renal cell carcinoma treatment (43 papers), Cancer Genomics and Diagnostics (25 papers) and Renal and related cancers (23 papers). Jeffrey Graham collaborates with scholars based in Canada, United States and Denmark. Jeffrey Graham's co-authors include Daniel Y.C. Heng, Shaan Dudani, Daniel Yick Chin Heng, Toni K. Choueiri, Aaron R. Hansen, Ulka N. Vaishampayan, Georg A. Bjarnason, Frede Donskov, J. Connor Wells and Lori Wood and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jeffrey Graham

51 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey Graham Canada 14 447 267 227 186 118 56 591
Samantha Di Donato Italy 11 161 0.4× 115 0.4× 296 1.3× 58 0.3× 105 0.9× 30 497
Annabelle Monnet Switzerland 5 408 0.9× 171 0.6× 374 1.6× 84 0.5× 17 0.1× 12 577
Jessica A. Hellyer United States 13 309 0.7× 235 0.9× 316 1.4× 148 0.8× 33 0.3× 29 738
Susan R. Schoen United States 10 213 0.5× 400 1.5× 133 0.6× 218 1.2× 38 0.3× 15 617
Dan George United States 6 123 0.3× 140 0.5× 73 0.3× 72 0.4× 29 0.2× 8 286
B. Sherman United States 10 95 0.2× 178 0.7× 320 1.4× 154 0.8× 24 0.2× 16 525
Rafael Caparica Belgium 16 255 0.6× 163 0.6× 329 1.4× 167 0.9× 65 0.6× 35 579
Catherine Tait United Kingdom 7 75 0.2× 178 0.7× 114 0.5× 123 0.7× 36 0.3× 10 336
Charles Nock United States 10 152 0.3× 132 0.5× 176 0.8× 53 0.3× 22 0.2× 15 377
Pablo Berlanga France 12 167 0.4× 186 0.7× 181 0.8× 97 0.5× 39 0.3× 54 492

Countries citing papers authored by Jeffrey Graham

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Graham more than expected).

Fields of papers citing papers by Jeffrey Graham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Graham. The network helps show where Jeffrey Graham may publish in the future.

Co-authorship network of co-authors of Jeffrey Graham

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Graham. A scholar is included among the top collaborators of Jeffrey Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Graham. Jeffrey Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hamilou, Zineb, Sunita Ghosh, Daniel Yick Chin Heng, et al.. (2025). Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma. The Oncologist. 30(9). 1 indexed citations
3.
Tanguay, Simon, Lori Wood, C. Kollmannsberger, et al.. (2025). Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World Study. Clinical Genitourinary Cancer. 23(3). 102342–102342. 1 indexed citations
4.
5.
Ghosh, Sunita, Lori Wood, Georg A. Bjarnason, et al.. (2024). Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database. Current Oncology. 31(8). 4704–4712. 3 indexed citations
6.
Ghosh, Sunita, Antonio Finelli, Lori Wood, et al.. (2023). Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System. JCO Global Oncology. 9(9). e2300271–e2300271. 1 indexed citations
7.
Gibson, Ian W., et al.. (2023). Redefining Renal Cell Carcinoma: A Molecular Perspective on Classification and Clinical Implications. SHILAP Revista de lepidopterología. 116–123.
8.
Navani, Vishal, T.B. Powles, Luís Meza, et al.. (2023). 1893P Immune-related adverse events from contemporary first-line combination therapies in metastatic renal cell carcinoma: Results from the IMDC. Annals of Oncology. 34. S1018–S1019. 1 indexed citations
9.
Graham, Jeffrey, J. Connor Wells, Shaan Dudani, et al.. (2022). Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy. European Journal of Cancer. 171. 124–132. 20 indexed citations
10.
Graham, Jeffrey, Arndt Vogel, Ann‐Lii Cheng, Georg A. Bjarnason, & Joel W. Neal. (2022). Cabozantinib after prior checkpoint inhibitor therapy in patients with solid tumors: A systematic literature review. Cancer Treatment Reviews. 110. 102453–102453. 5 indexed citations
11.
Velasco, Guillermo de, Òscar Reig, Francesco Massari, et al.. (2021). Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib. British Journal of Urology. 128(2). 254–261. 2 indexed citations
12.
Kushnir, Igal, Naveen S. Basappa, Sunita Ghosh, et al.. (2021). Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System. Clinical Genitourinary Cancer. 19(6). 521–530. 12 indexed citations
13.
Zhang, Han‐Bo, Naveen S. Basappa, Sunita Ghosh, et al.. (2021). Real-Word Experience of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis). 5(1). 21–29. 4 indexed citations
14.
Bhindi, Bimal, Jeffrey Graham, J. Connor Wells, et al.. (2020). Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. European Urology. 78(4). 615–623. 42 indexed citations
15.
Graham, Jeffrey, J. Connor Wells, Frede Donskov, et al.. (2019). Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. European Urology Oncology. 2(6). 643–648. 31 indexed citations
16.
Wells, J. Connor, Jeffrey Graham, Benoit Beuselinck, et al.. (2019). Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer. 18(4). e350–e359. 2 indexed citations
17.
Massari, Francesco, Vincenzo Di Nunno, Veronica Mollica, et al.. (2019). Adjuvant Tyrosine Kinase Inhibitors in Treatment of Renal Cell Carcinoma: A Meta-Analysis of Available Clinical Trials. Clinical Genitourinary Cancer. 17(2). e339–e344. 26 indexed citations
18.
Graham, Jeffrey, Amishi Y. Shah, J. Connor Wells, et al.. (2019). Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors. European Urology Oncology. 4(1). 102–111. 30 indexed citations
19.
Graham, Jeffrey, et al.. (2018). Baseline Edmonton Symptom Assessment System and Survival in Metastatic Renal Cell Carcinoma. Current Oncology. 25(4). 319–323. 11 indexed citations
20.
Graham, Jeffrey, et al.. (1989). Phosphorylation status of nuclear and cytosolic androgen receptors in the rat ventral prostate. The Prostate. 14(2). 91–101. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samantha Di Donato Breakdown of academic impact, for papers by Annabelle Monnet Breakdown of academic impact, for papers by Jessica A. Hellyer Breakdown of academic impact, for papers by Susan R. Schoen Breakdown of academic impact, for papers by Dan George Breakdown of academic impact, for papers by B. Sherman Breakdown of academic impact, for papers by Rafael Caparica Breakdown of academic impact, for papers by Catherine Tait Breakdown of academic impact, for papers by Charles Nock Breakdown of academic impact, for papers by Pablo Berlanga
Rankless by CCL
2026